摘要
目的:将多索茶碱与氨茶碱治疗支气管哮喘的临床疗效进行对比观察。方法:随机选取支气管哮喘急性发作期患者120例,并将其分为多索茶碱组和氨茶碱组,每组60例。多索茶碱组患者在常规治疗基础上使用多索茶碱,氨茶碱组患者在常规治疗上使用氨茶碱,在7 d后观察两组的临床疗效以及肺功能指标。结果:在有效率和肺功能指标对比中,多索茶碱组均优于氨茶碱组,两组比较差异均有统计学意义(P<0.05);在治疗过程中的不良反应发生率,多索茶碱明显优于氨茶碱组,两组对比差异有统计学意义(P<0.05)。结论:采用多索茶碱治疗支气管哮喘急性发作期患者取得了明显临床效果,具有起效较快,不良反应少的优点,值得在临床中推广和应用。
Objective： To compare and observe the clinical efficacy of Doxofylline and Aminophylline on bronchial asthma.Method： 120 cases of acute bronchial asthma patient were randomly selected and divided into two groups, 60 cases in each group.On the basis of conventional treatment, the Doxofyltine group was used Doxofylline, and the Aminophylline group was used Aminophylline.After 7 days, the clinical effects and lung function index of two group were compared.Result： Inthe efficient and lung function index comparison, the Doxofylline group were better than that of the Aminophylline group, the differences were statistically significant（P〈0.05）.In the treatment process of adverse reactions, the Doxofylline group was obviously better than that of the Aminophylline group, there was no statistically significant（P〈0.05）.Couclusion： Adopting the Doxofylline to treat patients with acute bronchial asthma, which get obvious clinical effect, it is worthy of popularization and application with those merit of work faster, less adverse reactions.
出处
《中外医学研究》
2015年第33期20-21,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
